[Studies on the mechanisms of the antiatherogenic effect of Ca-antagonists].
Birou
S
S
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000209:etiology; D002121:Calcium Channel Blockers / Q000494:pharmacology* / Q000627:therapeutic use; D002478:Cells, Cultured; D004110:Diltiazem / Q000494:pharmacology / Q000627:therapeutic use; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000473:pathology; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000473:pathology; D011817:Rabbits
D002121:Calcium Channel Blockers; D004110:Diltiazem